Diagnostic Imaging's Weekly Scan: October 19 — October 25

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

In a recently published study in Radiology, researchers found that pre-op breast MRI was associated with a 12.5 percent reduced 5-year cumulative incidence of recurrence for patients who underwent surgery for hormone receptor-negative breast cancer.

Study findings presented at the European Society for Medical Oncology (ESMO) conference revealed that Pluvicto in combination with the standard of care led to a 28 percent reduction in the risk of radiographic progression or death in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

Use of the radiotherapeutic agent 177Lu-edotreotide (ITM-11) demonstrated significantly higher absorption in gastroenteropancreatic neuroendocrine tumors than normal organs along with a favorable safety profile, according to SPECT research recently presented at the European Association of Nuclear Medicine (EANM) conference.

In a recent interview with Diagnostic Imaging, study co-author Dr. Emmanuel Deshayes shared his thoughts on the research and potential of the modality.

The authors of a new study found that over 70 percent of emergency referral requests for computed tomography (CT) scans lacked sufficient clinical reasoning to justify the CT.

In a recent interview with Diagnostic Imaging, Deepa Sheth, M.D., discussed the rising incidence of breast cancer, key considerations in supplemental imaging for women with dense breasts and use of the CIVIE RadPod platform to facilitate consistent quality and imaging reads by fellowship-trained breast radiologists.

Watch the video summary below of Diagnostic Imaging’s Weekly Scan.